Disseminated intravascular coagulation [defibrination syndrome]

D3_DISSEINTRAVASCCOAG

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 D65
  • Hospital discharge: ICD-9 2866
  • Hospital discharge: ICD-8 2864
  • Cause of death: ICD-10 D65
  • Cause of death: ICD-9 2866
  • Cause of death: ICD-8 2864

2 out of 7 registries used, show all original rules.

110

4. Check minimum number of events

None

110

5. Include endpoints

None

110

6. Filter based on genotype QC (FinnGen only)

110

Control definitions (FinnGen only)

Control exclude
D3_COAGDEF_PURPUR_HAEMORRHAGIC

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D65-D69
Name in latin
Coagulatio intravascularis disseminata

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 1279 631 631
Only index persons 817 418 399
Unadjusted period prevalence (%)
Whole population 0.02 0.02 0.02
Only index persons 0.02 0.02 0.02
Median age at first event (years)
Whole population 58.83 59.55 58.04
Only index persons 56.58 56.34 56.82

-FinnGen-

Key figures

All Female Male
Number of individuals 110 59 51
Unadjusted period prevalence (%) 0.02 0.02 0.02
Median age at first event (years) 53.41 47.09 60.71

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
105
Matched controls
1048
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D65
ICD-10 Finland
Disseminated intravascular coagulation [defibrination syndrome]
+∞
114.5
88
*
A41.9
ICD-10 Finland
Sepsis, unspecified
54.8
35.2
41
12
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
15.7
31.8
60
82
N17.9
ICD-10 Finland
Acute renal failure, unspecified
45.1
26.5
32
10
TK800
NOMESCO Finland
Hemodialysis
53.7
24.1
28
7
TK810
NOMESCO Finland
Hemofiltration
214.8
18.1
18
*
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
39.2
17.9
22
7
Z49.1
ICD-10 Finland
Extracorporeal dialysis
53.7
15.6
18
*
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
38.1
15.4
19
6
WX872
NOMESCO Finland
Intensive care
16.0
15.4
25
20
A49.9
ICD-10 Finland
Bacterial infection, unspecified
8.7
15.1
35
57
B03XA02
ATC
darbepoetin alfa; parenteral
42.9
15.0
18
5
A11CC03
ATC
alfacalcidol; systemic
32.6
14.9
19
7
L04AA06
ATC
mycophenolic acid; systemic
50.2
14.6
17
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
7.6
14.5
37
70
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
79.8
12.9
14
*
N08.2*D65
ICD-10 Finland
Glomerular disorders in disseminated intravascular coagulation [defibrination syndrome]
+∞
12.8
12
*
N18.0
ICD-10 Finland
End-stage renal disease
43.2
12.6
15
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
11.4
12.3
23
25
A12AA04
ATC
calcium carbonate; oral
53.3
12.2
14
*
127
Kela drug reimbursment
Transplant complication
34.6
12.0
15
5
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
10.6
11.8
23
27
A41.8
ICD-10 Finland
Other specified sepsis
39.9
11.6
14
*
V03AE01
ATC
polystyrene sulfonate; oral
28.8
11.5
15
6
J96.0
ICD-10 Finland
Acute respiratory failure
+∞
10.6
10
*
ZXD05
NOMESCO Finland
Urgent procedure
4.1
10.3
54
216
A40.3
ICD-10 Finland
Sepsis due to Streptococcus pneumoniae
44.6
10.2
12
*
WX730
NOMESCO Finland
Conventional respirator
29.3
10.1
13
5
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
15.5
10.1
16
12
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
10.8
10.0
19
21
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
5.1
10.0
35
94
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
33.5
9.6
12
*
Z94.0
ICD-10 Finland
Kidney transplant status
33.5
9.6
12
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
13.2
9.4
16
14
Z2446
NOMESCO Finland
Social worker
7.4
8.9
21
34
N08.2*D89.80
ICD-10 Finland
Immunoglobulin A (IgA) nephropathy
54.7
8.8
10
*
ZX120
NOMESCO Finland
Intravenous
6.0
8.8
25
52
KA1AE
NOMESCO Finland
Kidney ultrasound examination
18.3
8.8
13
8
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
22.3
8.7
12
6
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
30.4
8.7
11
*
WX882
NOMESCO Finland
High dependency care
11.4
8.3
15
15
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
36.5
8.2
10
*
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
7.0
8.2
20
34
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
14.6
8.1
13
10
TPX10
NOMESCO Finland
Implantation of vascular injection port
14.6
8.1
13
10
Z49.0
ICD-10 Finland
Preparatory care for dialysis
48.8
7.8
9
*
A12AA12
ATC
[U] calcium acetate anhydrous; systemic
+∞
7.4
7
*
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
21.9
7.3
10
5
L04AD01
ATC
ciclosporin; systemic
21.9
7.3
10
5
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
32.5
7.3
9
*
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
32.5
7.3
9
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
4.3
7.2
28
82
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
8.6
7.2
15
20
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
5.9
6.9
19
38
196
Kela drug reimbursment
Paricalcitol and cinacalcet
42.9
6.9
8
*
NDQ20
NOMESCO Finland
Amputation of finger
42.9
6.9
8
*
V03AE02
ATC
sevelamer; oral
42.9
6.9
8
*
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
42.9
6.9
8
*
R4110
NOMESCO Finland
Physiotherapy
3.3
6.8
42
178
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
9.7
6.8
13
15
JN4BD
NOMESCO Finland
Extensive body CT
4.7
6.5
22
56
321
Kela drug reimbursment
Paricalcitol and cinacalcet
74.2
6.5
7
*
H05BX01
ATC
cinacalcet; oral
74.2
6.5
7
*
TPH07
NOMESCO Finland
Cathetrisation of artery
4.6
6.4
22
57
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
28.6
6.3
8
*
GBB00
NOMESCO Finland
Tracheostomy
28.6
6.3
8
*
M10.0
ICD-10 Finland
Idiopathic gout
28.6
6.3
8
*
J80
ICD-10 Finland
Adult respiratory distress syndrome
+∞
6.3
6
*
C03CA01
ATC
furosemide; systemic
3.2
6.2
39
165
Z3226
NOMESCO Finland
Physiotherapist
3.5
6.2
32
116
J01MA12
ATC
levofloxacin; systemic
3.5
6.1
32
118
WX408
NOMESCO Finland
General anesthesy, balanced
3.0
6.1
43
195

Mortality – FinRegistry

Association

Association between endpoint D3_DISSEINTRAVASCCOAG and mortality.

Females

Parameter HR [95% CI] p-value
D3_DISSEINTRAVASCCOAG 3.462 [2.16, 5.55] < 0.001
Birth year 0.992 [0.98, 1.0] 0.086

During the follow-up period (1.1.1998 — 31.12.2019), 93 out of 307 females with D3_DISSEINTRAVASCCOAG died.

Males

Parameter HR [95% CI] p-value
D3_DISSEINTRAVASCCOAG 4.371 [2.68, 7.11] < 0.001
Birth year 0.986 [0.98, 1.0] 0.005

During the follow-up period (1.1.1998 — 31.12.2019), 108 out of 291 males with D3_DISSEINTRAVASCCOAG died.

Mortality risk

Mortality risk for people of age

years, who have D3_DISSEINTRAVASCCOAG.

N-year risk Females Males
1 0.317% 0.77%
5 2.11% 4.787%
10 4.958% 11.208%
15 8.941% 20.685%
20 14.772% 33.351%

Relationships between endpoints

Index endpoint: D3_DISSEINTRAVASCCOAG – Disseminated intravascular coagulation [defibrination syndrome]

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data